FDA reviewer backs Gardasil's effectiveness in male patients

09/6/2009 | Reuters

An FDA staff member affirmed the safety and efficacy of Merck & Co.'s vaccine Gardasil as a preventive regimen against genital warts caused by human papillomavirus in young men and boys. The employee's memo was released ahead of an FDA panel meeting Wednesday on the expanded use of Gardasil, which is approved to protect young women and girls against HPV.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC